Growth Hormone Receptor Blockade Improves Anticancer Drug Response in Mouse Model of Lung Cancer
Author ORCID
Abstract
The use of Growth hormone receptor antagonist, Pegvisomant improves the response of chemotherapy in mouse models of lung cancer
Status
Graduate
Department
Translational Biomedical Sciences
College
Graduate College
Campus
Athens
Faculty Mentor
Kopchick, John
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
COinS
Growth Hormone Receptor Blockade Improves Anticancer Drug Response in Mouse Model of Lung Cancer
The use of Growth hormone receptor antagonist, Pegvisomant improves the response of chemotherapy in mouse models of lung cancer